Novo Nordisk CEO: US health care changes won’t have big impact

In this video

Share

Novo Nordisk CEO: US health care changes won’t have big impact

Novo Nordisk CEO Lars Fruergaard Jorgensen comments on political risk, competition and the changing landscape of health care.
02:42
Wed, May 10 20171:30 AM EDT